GE
Genovis
Siste kurs
19,46 SEK
22.7.2026
Siste
30,00 SEK
+54.16%
Oppside
GENO
3 mnd+54,16%1 kursmål
6 mnd+54,16%3 kursmål
1 år+54,16%3 kursmål
Maks+54,16%4 kursmål
Nordea
HelsevesenBiotechnology
Om selskapet
Genovis was founded in 1999 by Sarah Fredriksson, who was CEO of Genovis until May 2015, when she became chairman of the board. The business was initially focused on nanoparticles intended for both the preclinical and clinical market.
Genovis
